Johan Jubin
Ceo
drugs
Melli Tech
Belgium
Biography
The Mellitech team has proven expertise in bioinformatics, as well as molecular and cellular biology, and is in the process of developing a new pharmaceutical target in pancreatic beta/alpha cells to provide a new direction in therapeutics for diabetes, in close corporation with institutional and private partners.
Research Interest
Pharma
